Showing Results for
- Academic Journals (23)
Search Results
- 23
Academic Journals
- 23
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedTumor-associated macrophages (TAMs) promote metastasis and tumor cell extravasation, survival, and growth. In hepatocellular carcinoma (HCC), the presence of TAM subpopulations correlates with poor outcome. In this issue...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedTrained immunity refers to the long-lasting memory traits of innate immunity. Recent studies have shown that trained immunity is orchestrated by sustained changes in epigenetic marks and metabolic pathways, leading to an...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedTargeted monoclonal antibody (mAb) therapies show great promise for the treatment of transplant rejection and autoimmune diseases by inducing more specific immunomodulatory effects than broadly immunosuppressive drugs...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedDysfunction of protein trafficking has been intensively associated with neurological diseases, including neurodegeneration, but whether and how protein transport contributes to oligodendrocyte (OL) maturation and myelin...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedDysregulation of Toll-like receptor (TLR) signaling contributes to the pathogenesis of autoimmune diseases. Here, we provide genetic evidence that tankyrase, a member of the poly(ADP-ribose) polymerase (PARP) family,...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedNext-generation sequencing (NGS) technology has advanced our understanding of the human microbiome by allowing for the discovery and characterization of unculturable microbes with prediction of their function. Key NGS...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-Reviewed[CD8.sup.+] T cell longevity regulated by metabolic activity plays important roles in cancer immunotherapy. Although in vitropolarized, transferred IL-9-secreting [CD8.sup.+] Tc9 (cytotoxic T lymphocyte subset 9) cells...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedGlutamate is the predominant excitatory neurotransmitter in the mammalian central nervous system (CNS). Excitatory amino acid transporters (EAATs) regulate extracellular glutamate by transporting it into cells, mostly...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedThe American Society for Clinical Investigation (ASCI) has selected Peter Tontonoz to receive 2022's Stanley J. Korsmeyer Award, recognizing his foundational discoveries in lipid metabolism and his dedication to...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedDespite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of [CD4.sup.+] T cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular populations that contribute...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedRare genetic disorders, when considered together, are relatively common. Despite advancements in genetics and genomics technologies as well as increased understanding of genomic function and dysfunction, many genetic...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedAlthough the memory capacity of innate immune cells, termed trained immunity (TI), is a conserved evolutionary trait, the cellular and molecular mechanisms involved are incompletely understood. One fundamental question...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedMerkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer that frequently carries an integrated Merkel cell polyomavirus (MCPyV) genome and expresses viral transforming antigens (TAgs). MCC tumor cells also...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedBACKGROUND. Currently, there is no disease-specific therapy for osteogenesis imperfecta (OI). Preclinical studies demonstrate that excessive TGF-[beta] signaling is a pathogenic mechanism in OI. Here, we evaluated...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedThe prevalence of metabolic syndrome continues to increase globally and heightens the risk for cardiovascular disease (CVD). Insulin resistance is a core pathophysiologic mechanism that causes abnormal carbohydrate...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedAntiretroviral therapy suppresses HIV replication but leaves a population of infected [CD4.sup.+] T cells with integrated proviruses. While most of these proviruses contain defects, such as deletions, some intact...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedMacrophages constitute a major immune component in tumor tissues, but how these cells adapt to and survive in the nutrient-depleted and lactic acid-induced acidic tumor microenvironments is not yet fully understood....
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedMultiple beneficial cardiovascular effects of HDL depend on sphingosine-1-phosphate (S1P). S1P associates with HDL by binding to apolipoprotein M (ApoM). Insulin resistance is a major driver of dyslipidemia and...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedThe functional integrity of [CD8.sup.+] T cells is tightly coupled to metabolic reprogramming, but how oxidative stress directs [CD8.sup.+] T cell metabolic fitness in the tumor microenvironment (TME) remains elusive....
-
From:Journal of Clinical Investigation (Vol. 132, Issue 7) Peer-ReviewedThe tumor microenvironment (TME) is reprogrammed by cancer cells and participates in all stages of tumor progression. The contribution of stromal cells to the reprogramming of the TME is not well understood. Here, we...